PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsTonic-clonic epilepsy
MeSH D004830 - tonic-clonic epilepsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D004830: 
Tonic-clonic epilepsy
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarbamazepine Carbamazepine  2012-09-20   
Carbamazepine Epitol  1986-09-17   
Levetiracetam Levetiracetam  2009-01-15   
Levetiracetam Levetiracetam Teva  2011-08-25   
Topiramate Topiramate  2009-03-27   
Taro PharmaceuticalCarbamazepine Carbamazepine  1996-10-03   
Phenytoin Extended Phenytoin  2006-09-05   
Levetiracetam Levetiracetam  2009-02-10   
Phenytoin Phenytoin  2004-03-08   
Carbamazepine Teril  2003-09-26   
Glenmark PharmaceuticalsTopiramate Topiramate  2009-03-27   
MylanLevetiracetam Levetiracetam  2008-11-04   
Phenytoin Phenytek  1998-12-28   
NATCO PharmaTopiramate Topiramate  2009-03-27   
Johnson & JohnsonTopiramate Topamax  1996-12-24   
CiplaLevetiracetam Levetiracetam  2009-01-15   
Topiramate Topiramate  2009-03-27   
Lupin ResearchPhenytoin Extended Phenytoin  2019-09-30   
Levetiracetam Levetiracetam  2009-01-15   
Topiramate Topiramate  2024-07-11   
SandozLevetiracetam Levetiracetam  2012-11-01   
NovartisCarbamazepine Tegretol  1982-01-01   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
10/10
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Johnson & Johnson
1
2
3
4
5
6
...
8
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use